Key facts
- This page summarizes Laurence Marton's Form 4 filing for RenovoRx, Inc. (RNXT).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 06 May 2025, 16:10.
Laurence Marton - 02 May 2025 Form 4 Insider Report for RenovoRx, Inc. (RNXT)
- Reporting relationship
- Director
- Issuer ticker
- RNXT
- Reported as of
- 02 May 2025
- Net transaction value
- +$3,072
- SEC form
- 4
- Accepted by SEC
- 06 May 2025, 16:10:20 UTC
- Prior SEC filing
- 09 Apr 2025
- Next SEC filing
- 03 Oct 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Laurence J. Marton
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Laurence Marton filed Form 4 for RenovoRx, Inc. (RNXT) on 06 May 2025.
Change
- Previous filing in this sequence was filed on 09 Apr 2025.
- Current net transaction value: +$3,072.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001862192
Primary reporting owner
Marton Laurence
- Relationship
- Director
- Address
- C/O RENOVORX, INC., 2570 W EL CAMINO REAL, SUITE 320, MOUNTAIN VIEW
- Signature
- /s/ Laurence J. Marton
- Signature date
- 06 May 2025
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
RNXT
transaction
Common Stock
Options Exercise
- Transaction value
- $3,072
- Shares
- +20,480
- Change %
- +45%
- Price
- $0.1500
- Shares after
- 66,164
- Date
- 02 May 2025
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
RNXT
transaction
Derivative
Stock Option (right to buy)
Options Exercise
- Transaction value
- $0
- Shares
- -20,480
- Change %
- -100%
- Price
- $0.000000
- Shares after
- 0
- Date
- 02 May 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 20,480
- Exercise price
- $0.1500
- Footnotes
- F1, F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Represents the reporting person's cash exercise of an outstanding stock option into shares of common stock, with no sale of such shares of common stock.
Footnote F2
Shares subject to the option are fully vested and immediately exercisable.